These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 468096)

  • 21. Functional cytoprotection by certain antacids.
    Szelényi I
    Acta Physiol Hung; 1984; 64(3-4):259-68. PubMed ID: 6598001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the effect of Krynica mineral water from the "Zuber" spring on alcohol-damaged gastric mucosa in rats].
    Mach T; Bogdał J; Stachura J; Kirchmayer S; Konturek J; Tetnowski J
    Folia Med Cracov; 1989; 30(1-2):63-9. PubMed ID: 2641935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric potential difference measurement as a quantification of gastrointestinal tolerability comparing a buffered acetylsalicylic acid formulation versus plain acetylsalicylic acid.
    Jost V; Kuhn I; Rogalla K; Theiss U; Lücker PW
    Arzneimittelforschung; 1992 May; 42(5):650-3. PubMed ID: 1530680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Protective effect of alkalies on ethyl alcohol-damaged gastric mucosa].
    Mach T
    Folia Med Cracov; 1989; 30(3-4):93-101. PubMed ID: 2641941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in stomach and duodenal mucosa caused by acetylsalicylic acid therapy].
    Prochazka E; Pötzi R; Ehringer H; Gangl A
    Acta Med Austriaca; 1988; 15(3):80-2. PubMed ID: 3146859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption, and effect on gastric mucosa, of buffered and non-buffered tablets of acetylsalicylic acid.
    Linnoila M; Lehtola J
    Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):61-4. PubMed ID: 885664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transmural gastric potential difference (PD) and intragastric diurnal pH profile with proglumide].
    Lembcke B; Lembcke C; Caspary WF
    Z Gastroenterol; 1983 Jul; 21(7):342-50. PubMed ID: 6613215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
    Vatier J; Ramdani A; Vitré MT; Mignon M
    Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent gastric-protective effect of antacid evaluated by measurement of transmucosal gastric potential difference.
    Bergmann JF; Caulin C; Simoneau G; Dorf G; Segrestaa JM
    Clin Pharmacol Ther; 1988 Nov; 44(5):546-9. PubMed ID: 3180636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new method for quantitation of ion fluxes across in vivo human gastric mucosa: effect of aspirin, acetaminophen, ethanol, and hyperosmolar solutions.
    Stern AI; Hogan DL; Isenberg JI
    Gastroenterology; 1984 Jan; 86(1):60-70. PubMed ID: 6315524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the transmural electric potential difference in the region of stomach ulcer. Local effect of sucralfate, aluminum hydroxide and magnesium trisilicate].
    Möckel W; Hausding P
    Fortschr Med; 1984 Jul; 102(25-26):709-12. PubMed ID: 6547921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of acetylsalicylic acid on the amphibian gastric mucosa. I. Electrophysiological and permeability changes.
    Spenney JG; Bhown M
    Gastroenterology; 1977 Oct; 73(4 Pt 1):785-9. PubMed ID: 19341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Stomach tolerance of buffered and unbuffered low-dose acetylsalicylic acid: an endoscopy controlled double-blind study in volunteers].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1990 Mar; 28(3):137-8. PubMed ID: 2188449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Measuring the potential difference of gastric mucosa as a means of quantifying the protective effect of Al-acetylglycyrrhetinate after a dose of acetylsalicylic acid (author's transl)].
    Altmayer P; Lücker PW; Kolb KH
    Arzneimittelforschung; 1981; 31(5):853-6. PubMed ID: 7196748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation of aspirin-magaldrate double-layer tablets: in vitro evaluation and cytoprotective activity in rats.
    al Gohary OM; el Din K; el Tahir H
    Boll Chim Farm; 1996; 135(7):421-8. PubMed ID: 9035555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro assessment of antacid efficacy using a computer-controlled 'artificial stomach-duodenum' model reproducing gastroduodenal flux regulation.
    Vatier J; Cai S; Célice-Pingaud C; Castela-Papin N; Mignon M; Farinotti R
    Therapie; 1996; 51(2):147-54. PubMed ID: 8763049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New approach for the in vitro evaluation of antacids.
    Vatier J; Vallot T; Vitre MT; Mignon M
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):175-9. PubMed ID: 2185759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Protective effect of misoprostol on the changes of transgastric potential difference induced by aspirin in man].
    Bergmann JF; Simoneau G; Naudin R; Caulin C; Segrestaa JM
    Rev Rhum Mal Osteoartic; 1991 Feb; 58(2):135-8. PubMed ID: 1904163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of cimetidine on the transmural gastric mucosal potential difference including the histological pattern of the gastric mucosa (author's transl)].
    von Kleist D; Stopik D; Hampel KE
    Z Gastroenterol; 1980 Apr; 18(4):185-90. PubMed ID: 7424072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.